Table 5.

PBCMs study cohort demographics.

	PRL		Gender			Ethnic group		Age of onset (year range)	Diagnostic latency (month range)	ALSFRS-R (/48) at blood withdraw (score range)	Cognitive impaired patients	Riluzole
	<0.5 slow	>1.5 fast	female	male	NA	caucasian	asian
B-ALS (n = 12)
	6	6	6	5	1	10	2	57–83	3–28	27–45	3	7
L-ALS (n = 12)
	6	6	2	10		11	1	32–70	2–74	24–48	1	7

Legend: PRL: progression rate to last visit. ALSFRS-R: Revised ALS Functional Rating Scale.